VCC Portfolio
Target resilient, high-value companies; structure investments with flexible preferreds, convertibles, and warrants to align income and growth objectives within ring-fenced mandates.
Targets & Objectives
Cedar Lifetech Ventures VCC focuses on biomedicine, biotechnology, smart manufacturing and related underlying assets. We prioritise mature, defensive, high-quality companies—often with overseas structures—that have completed R&D, secured product approvals and registrations, achieved commercialisation, earned global recognition, and continue to upgrade their technologies to sustain stable cash flows. We also back chain-leader-type enterprises and entrepreneurial teams capable of rapid market entry, dividend generation and value preservation/enhancement, using Singapore as a bridgehead to expand a resilient, secure medical industry chain across ASEAN and global markets.
Selection & Pipeline Formation
Target selection aligns tightly with Cedar Lifetech’s development plan: we continuously reserve and refine innovative companies with finished products and high added value, lead and invest from a Singapore base, and deploy value-investment and M&A to strengthen the chain. This approach supports local high-end intelligent manufacturing and international market expansion, improving overall ecosystem robustness while preserving industrial optionality for follow-on financings and strategic transactions.
Instruments & Capital Design
We employ flexible, mezzanine-like equity–debt hybrids—including preferred shares, convertible bonds and warrants—to tailor risk, yield and dilution to each asset’s stage and milestone profile. This toolkit is designed to meet strategic investment needs while enabling dividends within the investment cycle and planning for capital premiums and structured exit pathways. By maximising ecosystem, post-investment and integration capabilities, we enhance asset value and growth models, connecting operational milestones to financing cadence and exit readiness.
VCC Fit & Sub-Fund Calibration
Within the VCC umbrella, instruments and terms are calibrated at the sub-fund level—so income-oriented mandates can emphasise preferred returns and dividend flow, while growth-oriented vehicles lean into convertibles, warrants and milestone-linked step-ups. Ring-fencing preserves strategy purity and liquidity design for each pool of capital, allowing investors to select the exact risk/return and currency profile that matches their objectives without blending exposures across strategies.
Post-Investment Value Creation
After capital deployment, we use industry integration and ecosystem leverage to accelerate commercial traction and valuation build-up: resource allocation, market entry, team build-out and partner/channel access across Singapore and ASEAN. This execution model supports recurring dividends and value accretion while preparing assets for subsequent financing, M&A or public-market options, consistent with the “Chain Master + Fund” and NewCo engines that feed our pipeline.
